Article Details
Retrieved on: 2021-04-06 16:06:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Alexion is collecting more evidence to convince NICE that its anticoagulant reversal agent is also cost-effective for intracranial hemorrhage.
Article found on: pink.pharmaintelligence.informa.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here